- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03265769
Femoral or Radial Approach in Coronary Chronic Total Occlusion
September 10, 2021 updated by: Acibadem University
Femoral or Radial Approach in the Treatment of Coronary Chronic Total Occlusion: A Randomized Clinical Trial (FORT CTO TRIAL)
Pecutaneous coronary intervention (PCI) of chronic total occlusions (CTOs) is most commonly performed using bilateral transfemoral access and 8 French guiding catheters.
However, transfemoral approach (TFA) is associated with higher risk of vascular access complications.5
It has been reported that using transradial approach (TRA) reduces vascular complications and may be associated with a better clinical outcome.
Transradial access is also used in complex PCI interventions.There is a growing body of evidence regarding the use of this approach also in CTO procedures.
In available literature, all studies comparing TRA vs. TFA in CTO consisted of single center and single operator experience.
Besides, none of them is randomized.
To fill in the gap, we sought to examine the technique and outcomes of transradial vs. transfemoral CTO PCI in a contemporary multicenter randomized study.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
All consecutive patients referred for CTO PCI between August 2017 and July 2021 at Acibadem University Kocaeli Acibadem Hospital, Kocaeli; Erciyes University Medical Faculty, Kayseri; Istanbul University Cerrahpasa Medical Faculty, Haseki Cardiology Institute; Istanbul; Memorial Bahcelievler Hospital, Istanbul were screened for enrollment in the study.
The exclusion criteria included: (a) any acute coronary syndrome within 3 months; (b) severe heart failure issues; (c)severe renal failure (d) failure to provide written informed consent.The radial access group consisted of patients with single or bi-radial approach.
Any femoral artery puncture was considered a femoral case.
For example, a crossover from any radial to femoral access was considered a femoral case.
Procedures were performed by 4 interventional cardiologists, who are dedicated radial operators, at 4 different centers.
The protocol was approved by the institutional review board and all patients provided written informed consent.
Study Type
Interventional
Enrollment (Actual)
610
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Istanbul, Turkey
- Memorial Hospital
-
Istanbul, Turkey
- Haseki Cradiology Institute
-
Kayseri, Turkey
- Erciyes University
-
İstanbul, Turkey
- Acibadem University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 90 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Any patient with coronary total occlusion >3 months and indication for intervention
Exclusion Criteria:
- Acute coronary syndrome within 3 months
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: Transradial approach
target vessel revascularization via radial access site is labeled as transradial approach
|
radial route
|
|
ACTIVE_COMPARATOR: Transfemoral approach
target vessel revascularization via femoral access site is labeled as transfemoral approach
|
femoral route
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Procedural success
Time Frame: 24 hours
|
Technical success without any in-hospital event
|
24 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Major access site complications
Time Frame: 24 hours
|
Major bleeding, vascular complication requiring intervention and hematomas ≥ 10 cm
|
24 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Sevket Gorgulu, MD, Acibadem University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
August 8, 2017
Primary Completion (ACTUAL)
July 8, 2021
Study Completion (ACTUAL)
July 8, 2021
Study Registration Dates
First Submitted
August 27, 2017
First Submitted That Met QC Criteria
August 27, 2017
First Posted (ACTUAL)
August 29, 2017
Study Record Updates
Last Update Posted (ACTUAL)
September 13, 2021
Last Update Submitted That Met QC Criteria
September 10, 2021
Last Verified
September 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Atadek2017/13
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Coronary Occlusion
-
University Hospital UlmRecruitingChronic Total Occlusion | Chronic Total Occlusion of Coronary ArteryGermany
-
Lauri MansikkaniemiCompletedChronic Total Occlusion of Coronary Artery | Coronary Artery Disease (CAD) | Chronic Total Occlusion (CTO)Finland
-
Southeast University, ChinaUnknownCoronary Chronic Total OcclusionChina
-
OvalumTerminatedCoronary Chronic Total OcclusionGermany, South Africa
-
Sorlandet Hospital HFOslo University Hospital; HoloCare ASRecruitingPercutaneous Coronary Intervention | Chronic Total Occlusion of Coronary ArteryNorway
-
Universitaire Ziekenhuizen KU LeuvenUniversity Hospital, Antwerp; AZ Sint-Jan AV; Ziekenhuis Oost-Limburg; University... and other collaboratorsCompletedPercutaneous Coronary Intervention | Chronic Total Occlusion of Coronary ArteryBelgium
-
Shanghai MicroPort Rhythm MedTech Co., Ltd.The First Affiliated Hospital of Nanchang University; Shanghai Zhongshan Hospital and other collaboratorsRecruitingChronic Total Occlusion of Coronary ArteryChina
-
Seung-Whan Lee, M.D., Ph.D.Medtronic; Abbott Medical Devices; Biotronik SE & Co. KG; Dio MedicalRecruitingChronic Total Occlusion of Coronary ArteryKorea, Republic of
-
Academisch Medisch Centrum - Universiteit van Amsterdam...RecruitingChronic Total Occlusion of Coronary ArteryNetherlands
-
Praxis Medical Devices LtdNot yet recruitingChronic Total Occlusion of Coronary Artery
Clinical Trials on radial access site
-
Yonsei UniversityCompleted
-
Wujin People's HospitalNot yet recruitingHand Functions | Coronary Arterial Disease (CAD) | Distal Raidal Artery
-
University of British ColumbiaRecruiting
-
Wujin People's HospitalCompletedCoronary Artery Disease | Radial Artery Occlusion | Distal Radial ArteryChina
-
Huashan HospitalRecruiting
-
Beijing Luhe HospitalCompletedST Segment Elevation Myocardial InfarctionChina
-
Sixth Affiliated Hospital, Sun Yat-sen UniversityCompletedPerioperative Arterial Pressure MonitoringChina
-
Jordanian Research and Artificial Intelligence...CompletedRadial Artery Occlusion Following Coronary CatheterizationJordan
-
Carilion ClinicTerminatedAortic Stenosis | Aortic Valve Disease | Vascular Access ComplicationUnited States
-
University Hospital, CaenCompleted